| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 73 |
| 1 | DEXAMETHASONE | 68 |
| 2 | DEXAMETHASONE 1.5 MG | 66 |
| 3 | METHOTREXATE SODIUM | 65 |
| 4 | METHOTREXATE | 63 |
| 5 | CYCLOPHOSPHAMIDE | 53 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 53 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 53 |
| 8 | METHYLPREDNISOLONE | 52 |
| 9 | RITUXIMAB | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 1 | IBERDOMIDE | 1 | 0.0067 |
| 2 | NARATRIPTAN | 8 | 0.0057 |
| 3 | CIDOFOVIR ANHYDROUS | 7 | 0.0048 |
| 4 | PLERIXAFOR | 7 | 0.0047 |
| 5 | DELGOCITINIB | 1 | 0.0037 |
| 6 | TREOSULFAN | 9 | 0.0033 |
| 7 | BARICITINIB | 8 | 0.0026 |
| 8 | MILTEFOSINE | 1 | 0.0026 |
| 9 | CARMUSTINE | 10 | 0.0021 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 7 | 0.0047 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 11 | 0.0013 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 15 | 0.0011 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 16 | 0.0007 |
| 4 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 16 | 0.0005 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 6 | 0.0004 |
| 8 | Phenothiazine [EPC] | 11 | 0.0004 |
| 9 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |